This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Paediatrics

Positive CHMP opinion for adalimumab biosimilar
Positive CHMP opinion for adalimumab biosimilar
Management of childhood ITP
New guidance on diagnosis and management of allergic and non-allergic rhinitis published
Proposed rituximab and etanercept biosimilars recommended for approval in Europe
Proposed rituximab and etanercept biosimilars recommended for approval in Europe
Abeona Therapeutics receives orphan drug designation in EU for ABO-102
Abeona Therapeutics receives orphan drug designation in EU for ABO-102
NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old
NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old
ICCS and ESPU announce the launch of World Bedwetting Day
ICCS and ESPU announce the launch of World Bedwetting Day
Radiometer introduces MicroMode measuring for foetal scalp and neonatal capillary sampling
Radiometer introduces MicroMode measuring for foetal scalp and neonatal capillary sampling
Improving screening of newborns for critical congenital heart disease
Improving screening of newborns for critical congenital heart disease
Early detection and treatment of inherited metabolic disorders in newborns
Early detection and treatment of inherited metabolic disorders in newborns
UK lagging behind other nations in managing the most common mother to child viral infection in pregnancy
UK lagging behind other nations in managing the most common mother to child viral infection in pregnancy
Siemens Healthcare partners with UHNM NHS Trust to relieve imaging-related fears
Siemens Healthcare partners with UHNM NHS Trust to relieve imaging-related fears


Popular articles

Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction
Ide-cel provides 51% reduction in the risk of progression or death in R/R multiple myeloma
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora